AUL Calls New CDC Report on Increased Use of So-Called “Emergency Contraception” “the sad result of deceptive mislabeling”
“Deceptively labeled, these drugs and devices may be creating a false sense of security, exposing women to serious risks and ending young human life,” noted AUL’s Dr. Charmaine Yoest.
WASHINGTON, D.C. (2/14/13) – Americans United for Life President and CEO Dr. Charmaine Yoest called news today from the CDC that one in nine American women have used life-ending drugs mislabeled as “emergency contraception” the “sad result of deceptive mislabeling.”
AUL Attorney Anna Franzonello testified twice during the hearings leading up to the announced HHS guidelines for healthcare, expressing AUL opposition to the mislabeling of life-ending drugs as “contraception” and to concerns for violations of Americans’ First Amendment Rights of Conscience, should they be forced to subsidize the deceptively labeled life-ending drugs.
Noting the CDC report today, Franzonello made the following statement: “AUL’s concern that life-ending drugs are being deceptively labeled as “contraception” has only increased since the period that the CDC’s National Center for Health Services (NCHS) study examined. In 2010, the FDA approved a new drug, ella, which can kill a human embryo even after implantation.
“While the NCHS report suggests that use of so-called emergency contraception is common, recent studies show that Plan B—or the ‘morning after pill’— ‘prevent[s] fewer pregnancies than reported by the [World Health Organization].’ Even proponents of so-called ‘emergency contraception’ are acknowledging that ‘increased use [of Plan B] has not reduced rates of unintended pregnancies.’
“The NCHS tells us nothing about the complications that women have experienced from using these drugs and devices. Moreover, we know these life-ending drugs do nothing to prevent sexually transmitted diseases. The CDC, coincidentally, released a report today on the “epidemic” of STDs faced by our nation.
For more information on these life-ending drugs, click here.